首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Adolescents and Adults: Clinical Findings Drug Susceptibility and Therapeutic Efficacy
【2h】

Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Adolescents and Adults: Clinical Findings Drug Susceptibility and Therapeutic Efficacy

机译:青少年和成人的大环内酯类耐药肺炎支原体肺炎:临床发现药物敏感性和治疗功效。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We investigated differences in the clinical findings between 30 patients with macrolide-resistant Mycoplasma pneumoniae pneumonia and 43 patients with macrolide-sensitive M. pneumoniae pneumonia in adolescents and adults. No differences in clinical presentation were observed between the two groups. Among patients with macrolide-resistant Mycoplasma pneumoniae pneumonia, treatment was more effective in the groups that received quinolones and minocycline than in the group that received macrolides (P = 0.0361 and P = 0.0237, respectively).
机译:我们调查了在青少年和成人中30例对大环内酯类耐药的肺炎支原体肺炎患者和43例对大环内酯类敏感的肺炎支原体肺炎患者的临床发现差异。两组之间在临床表现上没有差异。在对大环内酯类耐药的肺炎支原体肺炎患者中,接受喹诺酮和米诺环素治疗的组比接受大环内酯类治疗的组更有效(分别为P = 0.0361和P = 0.0237)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号